New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs
Open Access
- 12 January 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 199
Abstract
Bladder cancer is a worldwide problem and improved therapies are urgently needed. In the search for newer strong antitumor compounds, herein, we present the study of three nitric oxide-releasing compounds and evaluate them as possible therapies for this malignancy. Bladder cancer cell lines T24 and 253J were used to evaluate the antiproliferative, antimigratory, and genotoxic effects of compounds. Moreover, we determined the NF-κB pathway inhibition, and finally, the survivin downregulation exerted by our molecules. The results revealed that compounds 1 and 3 exerted a high antiproliferative activity against bladder cancer cells through DNA damage and survivin downregulation. In addition, compound 3 reduced bladder cancer cell migration. We found that nitric oxide donors are promising molecules for the development of a new therapeutic targeting the underlying mechanisms of tumorigenesis and progression of bladder cancer.Keywords
Funding Information
- Comisión Sectorial de Investigación Científica (2018 - FID 37 - Grupo ID 882469, POS_NAC_2021_1_169813.)
- Agencia Nacional de Investigación e Innovación (2018 - FID 37 - Grupo ID 882469, POS_NAC_2021_1_169813.)
This publication has 40 references indexed in Scilit:
- Nitric oxide and cancer: a reviewWorld Journal of Surgical Oncology, 2013
- Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinomaWorld Journal of Surgical Oncology, 2013
- Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivativesBioorganic & Medicinal Chemistry, 2012
- The Histone Deacetylase Inhibitor Trichostatin A Synergistically Resensitizes a Cisplatin Resistant Human Bladder Cancer Cell LineJournal of Urology, 2011
- Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivoCancer Science, 2009
- Survivin expression is associated with bladder cancer presence, stage, progression, and mortalityCancer, 2007
- Clonogenic assay of cells in vitroNature Protocols, 2006
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cellsMutation Research/DNA Repair, 1995
- A simple technique for quantitation of low levels of DNA damage in individual cellsExperimental Cell Research, 1988